• <em>FCGR3A</em> F158V alleles frequency differs in multiple myeloma patients from healthy population
• A case of BIA-ALCL in which postoperative chest wall recurrence was highly suspected: the third reported case of BIA-ALCL in Japan
• A Case of Diffuse Large B Cell Lymphoma With Rapidly Developing Abdominal Distension As the Only First Clinical Presentation
• A consistency comparison between next-generation sequencing and the FISH method for gene rearrangement detection in B-cell lymphomas
• A Mystery in a Case: Unraveling the Complexity of Bing-Neel Syndrome
• A Rare Case of Atrial Septal Mass Secondary to Lymphoma: Case Report and Review of Literature
• A Rare Case of Refractory Nodal Marginal Zone Lymphoma in a Child, Successfully Cured by Allogeneic Stem Cell Transplant: A Case Report
• Anaplastic Large Cell Lymphoma Growing in the Pacemaker Pocket
• Application Effect of 18F-FDG PET/CT Technique in Diagnosis and Prognosis Evaluation of Lymphoma
• Applications of cell therapy in the treatment of virus-associated cancers
• Association of race/ethnicity and insurance with survival in patients with diffuse large B-cell lymphoma in a large real-world cohort
• Atrial fibrillation burden and clinical outcomes following BTK inhibitor initiation
• Atypical Cutaneous Manifestation of Mycosis Fungoides: A Case Report
• Bayesian sparse regression for exposure-response analyses of efficacy and safety endpoints to justify the clinical dose of valemetostat for adult T-cell leukemia/lymphoma
• Biomarkers of outcome in patients undergoing CD19 CAR-T therapy for large B cell lymphoma
• Cancer Statistics from the Shaukat Khanum Memorial Trust's Hospital-based Cancer Registry, Pakistan, 1994-2022: An Observational Study
• CD19 CAR T cells for B cell malignancies: a systematic review and meta-analysis focused on clinical impacts of CAR structural domains, manufacturing conditions, cellular product, doses, patient's age, and tumor types
• Challenges in overcoming advanced-stage or relapsed refractory extranodal NK/T-cell lymphoma: meta-analysis of individual patient data
• Changing profile of lung cancer clinical characteristics in China: Over 8-year population-based study
• Characterization of the genomic landscape of HIV-associated lymphoma reveals heterogeneity across histological subtypes
• Clinical and Biomarker Characteristic of Lymphoma Patients in Hasan Sadikin Lymphoma Registry
• Clinical features and prognostic analysis of colorectal extranodal NK/T cell lymphoma
• Clinical Impact of Microbiome Characteristics in Treatment-Naive Extranodal NK/T-Cell Lymphoma Patients
• Clinical Outcome of Patients Receiving Rituximab in Combination with Bendamustine in Indolent B-cell Lymphomas: A Single-center Institutional Study
• Clinicopathologic Insights and Molecular Oncogenesis: Understanding Epstein-Barr Virus-Induced B-cell Lymphoproliferations
• Clinicopathological and Molecular Characteristics of Rare EBV-associated Diffuse Large B-cell Lymphoma With IRF4 Rearrangement
• Clinicopathological diagnosis of Lennert lymphoma: a case report and review of the literature
• Comparison of Cox regression and generalized Cox regression models to machine learning in predicting survival of children with diffuse large B-cell lymphoma
• Comparisons of treatment outcomes of epcoritamab versus chemoimmunotherapy, polatuzumab-based regimens, tafasitamab-based regimens, or chimeric antigen receptor T-cell therapy, in third-line or later relapsed/refractory large B-cell lymphoma
• Complete detection of FR1 to FR3 primer-based PCR patterns of immunoglobulin heavy chain rearrangement in the BIOMED-2 protocol is associated with poor prognosis in patients with diffuse large B-cell lymphoma
• Concurrent identification of follicular lymphoma and papillary thyroid carcinoma
• Correlation Between the Hepatitis C Virus NS3 Protein and CD30 Expression in Diffuse Large B-cell Lymphoma
• Cutaneous T cell Lymphoma in Skin of Color: A Review
• DETECTION OF CIRCULATING TUMOR DNA FOR DISEASE MONITORING IN PATIENTS WITH PRIMARY CUTANEOUS DIFFUSE LARGE B-CELL LYMPHOMA, LEG TYPE
• Diffuse large B-cell lymphoma in the C8 root mimicking a schwannoma: illustrative case
• Diffuse large B-cell lymphoma with multiple bone involvement as the initial symptom of frontal mass: a case report
• Effect of body mass index on the prognosis of children and adolescents with high-grade mature B-cell non-Hodgkin lymphoma
• Erratum: An immunohistochemical study of diffuse large B-cell lymphoma with molecular subtyping based on Hans algorithm
• Evolving consolidation patterns and outcomes for a large cohort of primary CNS lymphoma patients
• Expanded profiling of WD repeat domain 5 inhibitors reveals actionable strategies for the treatment of hematologic malignancies
• Exploring the educational needs of patients with cutaneous lymphoma using an educational needs assessment tool
• Fluid Overload-Associated Large B-Cell Lymphoma with Light Chain Restriction Type Plasma Cell Infiltration: A Case Report
• Gamma-delta T-cell large granular lymphocytic leukemia in the setting of rheumatologic diseases
• Gastrointestinal Follicular Lymphoma of the Cecum Treated via Endoscopic Full-Thickness Resection
• Giant ovarian solid and cystic masses mixed with three types of tumors: A rare case report and literature review
• Harnessing Deep Learning for Accurate Pathological Assessment of Brain Tumor Cell Types
• Hematological Second Primary Malignancy in Pediatric Retinoblastoma: A Case Report and Systematic Review
• Hematolymphoid neoplasm mimicking endodontic lesions: case series and review of the literature
• Hemophagocytic syndrome secondary to invasive NK cell leukemia and T-cell lymphoma treated with the modified MINE protocol: report of three cases and literature review
• Identification of Quiescent Cells in a Zebrafish T-Cell Acute Lymphoblastic Leukemia Model Using Cell Proliferation Staining
• Identification, risk factors, and clinical course of CNS relapse in DLBCL patients across 19 prospective phase 2 and 3 trials-a LYSA and GLA/ DSHNHL collaboration
• Identify truly high-risk TP53-mutated diffuse large B cell lymphoma patients and explore the underlying biological mechanisms
• Impact of Primary Disease Site of Involvement by Early-Stage Follicular Lymphoma on Patient Outcomes
• Improving accuracy of GPT-3/4 results on biomedical data using a retrieval-augmented language model
• Infections and their prognostic significance before diagnosis of chronic lymphocytic leukemia, non-Hodgkin lymphoma, or multiple myeloma
• Intestinal Perforation in a Case of Peripheral T Cell Lymphoma after Initiation of Chemotherapy
• Investigation of the mutations in the genes involved in Janus kinase/signal transducer and activator of transcription pathway in canine large cell gastrointestinal lymphoma
• Isolated Monoclonal T-Cell Receptor Gene Rearrangement in a Lung Adenocarcinoma Harboring MET Exon 14 Skipping: Diagnostic Pitfall
• Knowledge, skills, and confidence gaps impacting treatment decision making in relapsed/refractory chronic lymphocytic leukemia and mantle cell lymphoma: a quantitative survey study in France, Germany, and the United States
• LMP1 enhances aerobic glycolysis in natural killer/T cell lymphoma
• Lumbosacral epidural lymphoma: A case report and comprehensive review of literature
• MEF2B C-terminal mutations enhance transcriptional activity and stability to drive B cell lymphomagenesis
• MegaAppendix: a rare case of mantle cell lymphoma in an appendix presented as volvulus
• Multiantigen T-Cell Hybridizers: A Two-Component T-Cell-Activating Therapy
• Navigating Diagnostic and Therapeutic Challenges in Primary Cutaneous Gamma/Delta T-Cell Lymphoma: A Case Study of Fatal Outcomes Within Two Months
• New and developing first line pharmacotherapies for treating non-hodgkin lymphoma
• Orbital Richter Transformation With Subsequent Orbital MALT-type Lymphoma in a Patient With Chronic Lymphocytic Leukemia
• Outcome of large B-cell lymphoma patients treated with tafasitamab plus lenalidomide either before or after CAR-T-cells
• Policy and perspective on outpatient programs for autologous hematopoietic cell transplantation and immune-effector cell therapy administration
• Predicting lymphoma prognosis using machine learning-based genes associated with lactylation
• Prevalence of S-methyl-5'-thioadenosine Phosphorylase (MTAP) Deficiency in Human Cancer: A Tissue Microarray Study on 13,067 Tumors From 149 Different Tumor Types
• Primary Cutaneous Spindle Cell B-Cell Follicle Center Lymphoma Presenting as Long-Standing Plaque of Cicatricial Alopecia: A Case Report With a Comprehensive Review of the Literature
• Prognostic stratification in DLBCL patients with aberrant MYC gene
• Pyoderma Gangrenosum in a 75-Year-Old Male With Follicular Diffuse Large B-cell Lymphoma
• Ready, AIM, stop: ibrutinib plus venetoclax in MCL
• Recurrence of an erythrodermic mycosis fungoides as a biologically indolent anaplastic large T-cell lymphoma initially misdiagnosed as being of donor origin
• Recurrent Hypoglycemia in a 67-Year-Old Woman with CD5- Positive Diffuse Large B-Cell Lymphoma
• Rethinking the role of surgical resection in the management of primary pituitary lymphoma
• Safety and activity of lenalidomide in combination with obinutuzumab in patients with relapsed indolent non-Hodgkin lymphoma: a single group, open-label, phase 1/2 trial
• Safety and efficacy of odronextamab in patients with relapsed or refractory follicular lymphoma
• Secondary Breast Burkitt Lymphoma Involving the Stomach, Ovary, Pancreas, and Bones: A Case Report
• Sequential high-dose methotrexate and cytarabine administration improves outcomes in real-world patients with primary central nervous system lymphoma: A report from the Australasian Lymphoma Alliance
• Small cell pattern of ALK-negative anaplastic large cell lymphoma with double-hit rearrangements of DUSP22 and TP63
• Spectrum of imaging findings of primary bone lymphoma in pediatric patients
• Standardization of CD30 immunohistochemistry staining among three automated immunostaining platforms
• Successful treatment of hemophagocytic intravascular large B-cell lymphoma with CNS involvement with BTK inhibitor combined with rituximab and high-dose methotrexate
• Synchronous Invasive Ductal Carcinoma of Breast and Diffuse Large B-cell Lymphoma: A Case Report
• T-Cell Neoplasms after B-Cell Neoplasms - The Pre-CAR T-Cell Era
• Targeted multiplex validation of CSF proteomic biomarkers: implications for differentiation of PCNSL from tumor-free controls and other brain tumors
• Tazemetostat for relapsed/refractory B-cell non-Hodgkin lymphoma with EZH2 mutation in Japan: 3-year follow-up for a phase II study
• TCP1 expression alters the ferroptosis sensitivity of diffuse large B-cell lymphoma subtypes by stabilising ACSL4 and influences patient prognosis
• The K9 lymphoma assay allows a genetic subgrouping of canine lymphomas with improved risk classification
• Three-year cardiovascular and non-cardiovascular adverse events in patients with chronic lymphocytic leukemia or small cell lymphocytic lymphoma treated with Bruton tyrosine kinase inhibitors acalabrutinib or ibrutinib: a real-world analysis
• Time-dependent change of T cell receptor clonality: From large plaque parapsoriasis to early mycosis fungoides
• Transcriptional activation of SIRT5 by FOXA1 reprograms glycolysis to facilitate the malignant progression of diffuse large B-cell lymphoma
• Transition From Epstein-Barr Virus (EBV)-Positive Rectal Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma in the Lung
• Trousseau's Syndrome: A Paraneoplastic Complication
• Tumor-informed ctDNA assessment as a valuable prognostic and predictive biomarker in diffuse large B-cell lymphoma
• Unique presentation of T-cell/histiocyte-rich large B cell lymphoma complicated with hemophagocytic lymphohistiocytosis: Case report and review of the literature
• Waldenstrom macroglobulinemia: a challenging case treated with anti-CD19 CAR-T cell therapy